CREATE-1: A Study to Assess the Efficacy and Safety of AXS-02 in Patients With CRPS-1

Clinical trial NCT02504008 · UNKNOWN

Trial details

NCT number: NCT02504008
Sponsor: Axsome Therapeutics, Inc.
Status: UNKNOWN
Phase: Phase 3
Study type: INTERVENTIONAL

Complex Regional Pain Syndrome Reflex Sympathetic Dystrophy

Start date: 2015-07-01
Primary completion: 2019-01-01
Enrollment: 190

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.